VALTOCO maintains orphan drug exclusivity for VALTOCO to treat episodes of frequent seizures SAN DIEGO, April 16, 2025 /PRNewswire/ -- Neurelis, Inc., today announced that the U.S. Food and Drug ...
CDSCO flagged three drugs as spurious and 94 as not of standard quality in August 2025, with spurious samples of Pan D, Pan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback